Perspective Therapeutics (CATX) Retained Earnings (2011 - 2026)

Perspective Therapeutics (CATX) has 16 years of Retained Earnings data on file, last reported at -$361.0 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 1900252.63% year-over-year to -$361.0 million; the trailing twelve-month figure through Mar 2026 stood at -$361.0 million (down 1900252.63% YoY), and the FY2025 full-year result was $110000.0, up 100.05% from the prior year.
• Retained Earnings declined to -$361.0 million in Q1 2026, from $110000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $110000.0 in Q4 2025 to a low of -$361.0 million in Q1 2026.
• A 5-year average of -$153.0 million and a median of -$127.8 million in 2023 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings soared 100.05% in 2025 and slumped 1900252.63% in 2026, its largest moves.
• Tracing CATX's Retained Earnings over 5 years: stood at -$105.9 million in 2022, then tumbled by 43.9% to -$152.4 million in 2023, then slumped by 52.01% to -$231.7 million in 2024, then surged by 100.05% to $110000.0 in 2025, then slumped by 328308.18% to -$361.0 million in 2026.
• Business Quant data shows CATX's Retained Earnings at -$361.0 million in Q1 2026, $110000.0 in Q4 2025, and -$297.4 million in Q3 2025.